18th August 2018
In response to rising concern over 'monkey dust', David Nutt calls for expanded drug safety testing and a frank discussion on the roles of the UK's classification system compared to drug harms
24th January 2017
The ACMD has voted to keep THCv, a non-psychoactive cannabinoid with a promising properties for a range of health conditions, in Schedule 1 away from the hands of researchers.
22nd December 2016
The WHO has commissioned a cannabis review before the Commission for Narcotic Drugs 2018 meeting. This will be first WHO cannabis review since 1935!
10th December 2013